Osicent — Osimertinib 80 mg, 30 product-page.units_short, Incepta Pharmaceuticals
100% original product

Osicent (Osimertinib) 80 mg Tablets

12312₴ 13191₴ -7%

Osicent 80 mg (Osimertinib) is a third-generation EGFR tyrosine kinase inhibitor (TKI) used to treat non-small cell lung cancer (NSCLC).

Manufacturer: Incepta Pharmaceuticals. Each pack contains 30 tablets. It is designed to inhibit both EGFR-sensitizing and EGFR T790M-resistance mutations, effectively blocking tumor growth.

Key Feature:

Osimertinib crosses the blood-brain barrier, showing significant efficacy against central nervous system (CNS) metastases.

Indicated for the treatment of adult patients with metastatic NSCLC:

  • 🔹 First-line treatment: Patients whose tumors have EGFR exon 19 deletions or exon 21 L858R mutations.
  • 🔹 Second-line treatment: Patients with EGFR T790M mutation-positive NSCLC (detected after progression on prior EGFR TKI therapy).
  • 🔹 Adjuvant therapy: After tumor resection in patients with EGFR mutation-positive NSCLC.

Packaging: 80 mg tablets.

⚠️ ADMINISTRATION PROTOCOL:

  • Recommended Dose: 80 mg orally once daily.
  • Timing: Take at the same time each day, with or without food.
  • Administration: Swallow the tablet whole with water. Do not crush, split, or chew.
  • For Difficulty Swallowing: The tablet can be dispersed in 50 mL of non-carbonated water (stir until dispersed, do not crush) and swallowed immediately.
  • Hypersensitivity to Osimertinib.
  • Pregnancy and breastfeeding (embryo-fetal toxicity).
  • History of Interstitial Lung Disease (ILD) or drug-induced pneumonitis.
  • Concomitant use with St. John's Wort.

Common adverse reactions include:

  • 🩸 Cardiac/Labs: QT interval prolongation, decreased leukocytes/platelets.
  • 📉 Dermatologic: Rash, dry skin, paronychia (nail infection/inflammation), pruritus.
  • 🌀 Respiratory/GI: Diarrhea, stomatitis, interstitial lung disease (ILD) — requires immediate medical attention.
  • Patients should monitor for nail changes and skin rash regularly.
Active ingredient
Manufacturer
Incepta Pharmaceuticals
Dosage 80 mg
Dosage form Tablets
Tablets per pack 30
100% original product
Delivery across Ukraine
Alternatives

Similar products

Osimert 80 mg Everest
View
Everest
80 mg 30 tablets
7915₴ 9674₴
Tagrix 80 80 mg Beacon Pharmaceuticals
View
Beacon Pharmaceuticals

Tagrix 80

80 mg 30 tablets
34298₴ 37376₴
Customer reviews

What Customers Say

No reviews yet

Your review can be the first!

Contact us

Choose a convenient way to contact

We work daily from 9:00 to 20:00